Molybdenum cofactor (Moco) is an enzyme cofactor found in almost all organisms from all kingdoms of life and plays central roles in various metabolic and catabolic pathways. Moco cannot be acquired from the environment and hence, must be biosynthesized de novo through a conserved pathway. Moco biosynthesis plays important roles in various scientific contexts and is associated with various medical and environmental problems. For example, in humans, Moco is essential in various detoxification pathways, and perturbation in its biosynthesis causes a fatal and currently incurable disease. In bacteria, Moco plays a key role in virulence. Therefore, a fundamental understanding of Moco biosynthesis is necessary.
We recently discovered a previously undescribed Moco biosynthetic intermediate 3’,8-cH2GTP, which lead to the revision in the functions of two biosynthetic enzymes, MoaA and MoaC (Fig. 1; JACS 2013, 135, 7019-32; PNAS 2015, 112, 6347-52.). We are now characterizing the mechanisms of these enzymes with the following specific questions.
• How does MoaA control the highly reactive free radicals to produce the structurally unique cyclic nucleotide, 3′,8-cH2GTP?
• How does MoaC catalyze a complex rearrangement of 3′,8-cH2GTP into cPMP? How does the protein conformational dynamics play roles in this process?
These questions will be addressed by taking multidisciplinary approaches combining enzymology, organic chemistry, NMR, EPR, and X-ray crystallography.
The project will be developed in future to understand the later steps of the pathway involving sulfur trafficking and metabolisms, relevant to cellular signaling in humans and infectious disease in bacteria.